Related Experiment Video
Updated: Jan 27, 2026

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene
K Wiechen1, L Diatchenko, A Agoulnik
1Institute of Pathology, Charité, Humboldt University Berlin, Berlin, Germany.
Abstract:
To identify novel markers differentially expressed in ovarian cancer versus normal ovary, we hybridized microarrays with cDNAs derived from normal human ovaries and advanced stage ovarian carcinomas. This analysis revealed down-regulation of the caveolin-1 gene (CAV1) in ovarian carcinoma samples. Suppression of CAV1 in ovarian carcinomas was confirmed using a tumor tissue array consisting of 68 cDNA pools from different matched human tumor and normal tissues. Immunohistochemistry demonstrated expression of caveolin-1 in normal and benign ovarian epithelial cells, but loss of expression in serous ovarian carcinomas. In low-grade carcinomas, redistribution of caveolin-1 from a membrane-associated pattern observed in normal epithelium to a cytoplasmic localization pattern was observed. No expression of caveolin-1 was detectable in four of six ovarian carcinoma cell lines investigated. In SKOV-3 and ES-2 carcinoma cells, which express high levels of the caveolin-1 protein, phosphorylation of the 22-kd caveolin-1 isoform was detected. Inhibition of both DNA methylation and histone deacetylation using 5-aza-2'deoxycytidine and Trichostatin A, respectively, relieves down-regulation of caveolin-1 in OAW42 and OVCAR-3 cells which is in part mediated by direct regulation at the mRNA level. Expression of CAV1 in the ovarian carcinoma cell line OVCAR-3, resulted in suppression of tumor cell survival in vitro, suggesting that the CAV1 gene is likely to act as a tumor suppressor gene in human ovarian epithelium.
Insights
Caveolin-1 (CAV1) is downregulated in ovarian cancer, acting as a tumor suppressor gene. Restoring CAV1 expression inhibits ovarian cancer cell survival, highlighting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Gene Expression Analysis
Background:
- Ovarian cancer is a leading cause of cancer death in women.
- Identifying novel biomarkers for early detection and targeted therapy is crucial.
- Caveolin-1 (CAV1) has been implicated in various cancers, but its role in ovarian cancer requires further elucidation.
Purpose of the Study:
- To identify novel differentially expressed genes in ovarian cancer compared to normal ovarian tissue.
- To investigate the role of caveolin-1 (CAV1) as a potential tumor suppressor gene in ovarian cancer.
Main Methods:
- Microarray analysis of normal ovaries and advanced ovarian carcinomas.
- Confirmation of CAV1 down-regulation using tumor tissue arrays and immunohistochemistry.
- Analysis of CAV1 expression and phosphorylation in ovarian cancer cell lines.
- Investigating the effect of epigenetic modifiers on CAV1 expression.
- Assessing the impact of CAV1 re-expression on ovarian cancer cell survival in vitro.
Main Results:
- Caveolin-1 (CAV1) gene expression is significantly down-regulated in ovarian carcinoma samples.
- Loss of CAV1 expression was observed in serous ovarian carcinomas, with altered localization in low-grade tumors.
- CAV1 re-expression in ovarian cancer cells suppressed tumor cell survival in vitro.
- Epigenetic modifications (DNA methylation and histone deacetylation) contribute to CAV1 down-regulation.
Conclusions:
- Caveolin-1 (CAV1) functions as a tumor suppressor gene in human ovarian epithelium.
- Down-regulation of CAV1 is a common event in ovarian cancer development.
- Restoring CAV1 expression may represent a potential therapeutic strategy for ovarian cancer.
More Related Videos
08:39Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
Published on: January 3, 2015
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Related Concept Videos
Gene Regulation During Sporulation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Circadian Rhythms and Gene Regulation